Medicine’s profit motive
Big Pharma has the NHS in its grip – and patients are paying the price.
By
Phil Whitaker
Phil Whitaker is a contributing writer to the New Statesman.
Latest articles
Features on
All Articles
It will take more than cash to repair the NHS
Labour must make hard decisions on the future of social care.
By
Christmas disease is not as festive as it sounds
The story of Stephen Christmas – for whom the clotting condition was named – highlights both medical advances and…
By
Rachel Reeves’ Budget will stabilise the NHS – but only reform will save it
Health needs that aren’t met in primary care simply turn up in secondary care.
By
For assisted dying to work, GPs need to know their patients
Ending a life must be a choice made between alternatives; not one taken because of a failure to provide…
By Making a new weight-loss drug available on the NHS will break the system
There isn’t capacity to accommodate the millions that would seek it.
By AI won’t solve all of medicine’s problems
Technology is invaluable to the future of healthcare – but we must also be realistic.
By
Medicine wars
A revolt over patient safety and declining expertise is tearing the medical establishment apart.
By The tension between patients’ rights and public safety
The report into the case of Valdo Calocane may impact the government’s commitment to “modernise” the Mental Health Act.
By